Westfield Capital Management CO LP Global Blood Therapeutics, Inc. Transaction History

Westfield Capital Management CO LP

  • $21.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$37.65 - $63.77 $8.2 Million - $13.9 Million
-217,850 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$52.76 - $74.49 $691,050 - $975,670
-13,098 Reduced 5.67%
217,850 $12 Million
Q2 2020

Aug 13, 2020
BUY
$48.73 - $81.82 $3.4 Million - $5.71 Million
69,779 Added 43.3%
230,948 $14.6 Million
Q1 2020

May 14, 2020
BUY
$41.72 - $87.2 $6.72 Million - $14.1 Million
161,169 New
161,169 $8.23 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email